Objective-To study the similarities and diVerences between the non-automated labour intensive Ewing hearing test and the less labour intensive automated CAPAS (Compact Amsterdam PaedoAudiometrical Screening) hearing test. Setting-A multicentre study in which all the children born in the eastern part of the Netherlands between 1 January 1996 and 1 April 1997 were routinely screened for hearing impairment at 9 months of age. Methods-DiVerences and similarities between the two methods were described for the proportion of children who failed every test, the percentage of referred children, the yield of bilateral and unilateral otitis media with eVusion (OME), the positive predictive value of the third test result, and the yield of persistent OME after 4-6 months' follow up at an ENT department. Results-12 603 infants were screened with the CAPAS test and 17 496 with the Ewing test. There were diVerences between the CAPAS and Ewing tests respectively in the proportions of children lost to follow up (10.1% v 15.2%), the proportions of children referred diagnosed with OME (59% v 81%), the yield of bilateral otitis media with eVusion (2.4% v 3.0%), and the yield of persistent OME after 4-6 months' follow up (1.1% v 1.6%). Conclusions-The CAPAS test is more practical than the Ewing test, but the nonautomated Ewing test seems to be more reliable and valid for detecting conductive hearing loss. (J Med Screen 1999;6:188-192) Keywords: otitis media with eVusion; hearing screening; infants Since 1964, screening for hearing loss in infants has formed part of routine care, because deafness in the early years of life can hinder the development of communication.
Since 1964, screening for hearing loss in infants has formed part of routine care, because deafness in the early years of life can hinder the development of communication. [1] [2] [3] [4] [5] To identify aVected children in the Netherlands at the earliest possible stage the Dutch Foundation for the Deaf and Hearing Impaired Child introduced the Ewing distraction test for the screening of hearing in 1965.
The aim of this screening test is to detect three groups of aVected children: (a) children with sensorineural hearing loss; (b) children with persistent conductive hearing loss of which otitis media with eVusion (OME) is the main cause; and (c) children with both sensorineural and conductive (mixed) hearing loss. However, the test cannot diVerentiate between a conductive and sensorineural hearing loss.
Nowadays, more than 90% of the infants born in the Netherlands are screened when they are 9 months old. 6 Children who fail this hearing test are rescreened at monthly intervals. Those who fail three times in succession are normally referred to a GP for further evaluation and potential referral to an otolaryngologist or an audiology centre.
Over the past 10 years the emphasis in screening programmes for permanent hearing impairment has switched to the neonatal period in several countries, 7 and in this context the auditory brainstem response and the transient evoked otoacoustic emission have been used successfully. 8 Both methods are based upon a response to wide band clicks presented in the ear. This neonatal screening often replaces the hearing screening programmes in the latter part of the first year. It is, however, uncertain what such screening, or any case finding method, would contribute to the detection of conductive hearing losses (OME). Secondary prevention of auditory/linguistic disability has become the chief justification for early surgical intervention in OME during the past two decades, 9 but a recent trial showed that the insertion of ventilation tubes had only a modest eVect on language development. 10 Timing and accuracy of screens will aVect the diVerence between the natural and the screened/treated disease course, therefore both these variables are of importance to the strategy for otological treatment. This raises questions about the eYciency of screens, the severity of the disease, and the numbers aVected.
The eVectiveness of any screening test depends on the nature of the disorder, the screening procedure, and the possibility of eventual treatment. 11 12 To justify screening as a policy the screening procedure must be practical, reliable, valid, and reasonably low in cost. Moreover, if a disorder is detected, the treatment must be eYcacious, available, accessible, and early treatment must be more eVective than later treatment. 13 At present two hearing screening tests are being used in the Netherlands-namely, the Ewing test and the Compact Amsterdam Paedo-Audiometrical Screening (CAPAS) test. The technique of these tests is based on expected responses: between 9 and 13 months the infant will be able to localise sounds directly.
14 The Ewing test is fairly labour intensive: it has to be carried out by two people and the outcome of the measurements written on an administration form, for processing by a central computer. Moreover, the auditory stimuli are generated manually.
To enhance eYciency and objectivity a new method has been developed, called the CAPAS test. The principles of the CAPAS test are the same as those of the Ewing test; but the new CAPAS test can be carried out by one person, the data can be stored immediately on a computer, and the auditory stimuli are presented digitally.
This study aimed at comparing the performance of these two screening procedures in a field setting. We chose as measures of performance to be compared: (a) the proportion of children lost to follow up; (b) the proportion of children who failed every test; (c) nominal OME prevalence; (d) the positive predictive value of the screen; and (e) the prevalence of persistent cases of OME among those found after 4-6 months' follow up at an ENT department.
Methods

THE HEARING TESTS
The Ewing screening test for hearing is carried out by two people: an observer, who focuses the attention of the child just before presentation, and a tester, who presents the various sounds. The test has to be performed in a quiet environment in which the parent sits on a chair with the child on his/her lap. Both the parent and the child have to look in the observer's direction, while the tester produces the auditory stimuli behind the parent and child, on the right and the left, exactly at one metre distance and at an angle of 45 degrees. The sounds presented are a music box, a rattle, hitting a porcelain cup, banging a metal spoon, and a voice or a song. The main frequencies of the sounds lie between 250 and 8000 Hz, and the intensity of the sound is about 35 dB SPL. Each sound is presented for 5 seconds, and while the sounds are being presented, the observer stops actively drawing the child's attention. If a child does not react to one of the sounds, the sound is presented again in another standardised way. The total test takes about 5 minutes. The test result is adequate if the child reacts correctly to all four sounds on the left and right. 15 If the child fails the screening test, he/she is rescreened 1 month later. If the child also fails this second test, he/she is recalled for a more comprehensive third screening test. During this third test the sounds are also presented louder if a child does not react to 35 dB. The aim of this is to get an idea about the level of the hearing loss. However, the child will still be referred if there is no response to sounds at 35 dB.
In contrast with the Ewing test, the auditory stimuli in the CAPAS test comprise digitised natural sounds. The speech frequency spectrum lies between 500 and 6000 Hz and the sound level is about 35 dB. Moreover, a computer automatically records the test results. 16 
STUDY POPULATION
The study population comprised all the infants born in seven healthcare regions in the eastern part of the Netherlands between 1 January 1996 and 1 April 1997, who were screened for hearing impairment at 9 months of age.
Children who failed the screen were referred to one of the 13 participating ENT outpatient clinics for tympanometry and otoscopy.
In four of the seven regions, 17 496 children were screened with the Ewing screen, while in the other three regions the CAPAS screen was used for 12 603 children. EVALUATION 
CRITERIA
DiVerences and similarities between the two screens were evaluated from the proportion of children lost to follow up, the proportion of children who failed every screening test, the proportion of referred children diagnosed with OME, the prevalence of bilateral and unilateral otitis media with eVusion, and the positive predictive value of the third screening. The proportion of infants lost to follow up was determined by counting (a) the number of children who never participate in the screening programme (also called the non-attendance rate); (b) the number of children who failed one test but did not return for the next test; and (c) the number of children who failed three times in succession but did not visit an ENT department for diagnosis.
The proportion of children who failed every test was computed as the ratio between the number of children who failed the test and the total number of children tested.
The proportion of children referred was calculated as the number of children who failed the screen divided by all the children who participated in the first screening test.
The yield of OME was calculated by dividing the number of children diagnosed with bilateral OME by the total number of children who participated in the first test.
The positive predictive value of the third test was calculated as the number of children subsequently diagnosed with bilateral OME as a proportion of the total number of children who were seen at an ENT department.
The yield of persistent OME (that is, OME during the 4-6 months' follow up at an ENT department) was calculated by dividing the number of children with bilateral OME at three of the four ENT visits by the number of children who participated in the first test.
To diagnose OME the otorhinolaryngologists used the classification algorithm described by Cantekin 17 and the MOMES study, 18 and summarised in figure 1. In this algorithm, OME is indicated by a type B tympanogram or a type C2 tympanogram. Where tympanometry was not possible, OME had to be diagnosed by otoscopy.
In addition, a list was made of all the children in the study population diagnosed with sensorineural hearing loss at the six audiology centres in the eastern part of the Netherlands. These data were used to estimate the detection rates of sensorineural hearing loss using the Ewing screen and the CAPAS screen. Figure 2 shows the breakdown for the CAPAS screen: 12 603 children were born between 1 January 1996 and 1 April 1997; 721 (5.7%) of them did not respond to the invitation for screening; 3812 out of the 11 882 (32.1%) infants failed the first test; 1301 (36.6%) out of the 3552 subsequent participants failed the second test; and 591 (53.6%) out of the 1102 children who participated in the third test failed. Figure 3 shows the breakdown for the Ewing screen: 17 496 children were born between 1 January 1996 and 1 April 1997; 1736 (9.9%) of them did not respond to the invitation for screening; 4662 (29.6%) out of the 15 760 infants failed the first test; 1665 (39.7%) out of the 4197 subsequent participating infants failed the second test; and 774 (55.4%) out of the 1397 children who participated in the third test failed. Tables 1 and 2 show the diVerences and similarities between the CAPAS and Ewing screens. DiVerences were found in: (a) the 80%) ; (e) the yield of bilateral OME (2.4% v 3.0%); (f) the yield of persistent OME after 4-6 months' follow up at an ENT department (1.1% v 1.6%). The proportion of children diagnosed with bilateral OME varied from 53% to 93% between 13 hospitals. At the hospitals in which the "CAPAS patients" were diagnosed, the percentage varied from 53% to 74%. At the Ewing hospitals, this percentage varied from 73% to 93%.
Results
During the study period five children in the Ewing region were diagnosed with sensorineural hearing loss: one child had never been screened, two had been referred for more sensitive testing after failing the second screening test, and two had failed three times. One of the infants had been referred to an audiology centre immediately after the third test; the other child had been referred to a GP, who referred the child to an audiology centre. In the CAPAS region, nine children were diagnosed with sensorineural hearing loss: three infants had never been screened, three had been referred for more sensitive testing after failing the first test, one had been referred after failing the second test, and two children had been referred to an ENT department where sensorineural hearing loss was suspected.
Discussion
The proportion of children lost to follow up (10.1% v 15.2%) and the proportion of children diagnosed with persistent bilateral OME (59% v 81%) diVered between the CAPAS and Ewing tests. The apparent diVerences in the yield of bilateral OME (CAPAS 2.4% v 3.0% Ewing) might in fact be due to this. When the denominator was adjusted for loss to follow up, the yield was 466/17 496 = 2.7% and 289/12 603 = 2.3% for the Ewing test and the CAPAS test respectively. Another diVerence was found in the predictive value (CAPAS 58% v Ewing 80%). In contrast with yield this measure is less sensitive to loss to follow up: only if the tested children are a selective sample will the predictive value be influenced. No diVerences were found in the proportion of children who failed every screening test and in the proportion of infants referred to an ENT department for diagnosis.
There is no epidemiological reason to believe that the very small demographic and climatic diVerences between the regions would lead to diVerences in prevalence of OME. The diVerences in performance (particularly the diVerences in predictive values) between the two tests were therefore probably due to the procedures themselves.
A possible explanation for some of the diVerence in the yield of OME might be regional diVerences in diagnostic skills or stringency of criteria between the diVerent regions or the otorhinolaryngologists. The proportion of children diagnosed with bilateral OME varied from 53% to 93% between the 13 hospitals, while the percentages of children diagnosed according to the algorithm varied from 89% to 98% between hospitals. However, tympanometry was not performed in 38% of all diagnoses (34% and 43% in the Ewing and the CAPAS region, respectively). Nine per cent more children failed tympanometry in the CAPAS region. If they had otherwise been diagnosed with bilateral OME, 331 (instead of 289) children would have had bilateral OME. In this case the yield would have been 331/11 882 = 2.8%. However, it is unlikely that all the extra tympanometry failures were due to diVerences in the true proportions having bilateral OME. DiVerences in diagnosis can therefore also partly explain the diVerences in yield.
A third possible explanation is that there were diVerences in the time interval between the third screening test and the moment of diagnosis at an ENT department, or in the ages of the children (that is, diVerences in the duration of the total Ewing and CAPAS screening programmes). Analysis of the time intervals between the third screening test and the moment of diagnosis, as well as the ages of the infants, showed no diVerences: 0.7 v 0.8 month and 13.8 v 13.7 months for the Ewing and CAPAS tests respectively.
The question then arises: to what in the tests themselves are the diVerences chiefly due?. For example, the auditory stimuli diVer, the Ewing test is not automated and the auditory stimuli of the CAPAS test are known to be a little louder. The latter could result in a lower proportion of children who fail the test. The CAPAS screen also uses more frequencyspecific stimuli. To analyse the diVerences between the CAPAS and Ewing methods more fully, it would be necessary for all the children to undergo ENT evaluation after screening. Then it would be possible to calculate the sensitivity and specificity of each test. As in many studies of screening we could only calculate the positive predictive value of the screen, because the children who passed the screening were not referred for ENT evaluation. It should also be noted that the infants were diagnosed 1-4 weeks after failing the screening; this assumes that children with persistent hearing loss were detected and that they were persistent for that period. This situation also applies to clinical practice, because the moment of diagnosis will always be at least 2-4 weeks after referral.
It should be noted that the detection rate of sensorineural hearing loss, at 0.04 per 1000, was lower than the expected prevalence of 1 per 1000. The Ewing test traced five children with sensorineural hearing loss, while the CAPAS test traced nine children with sensorineural hearing loss. The CAPAS test seems to be at least as eVective in detecting children with sensorineural hearing loss, either because the test method was more sensitive or because the loss to follow up was lower. However, the numbers of cases with a sensorineural hearing loss are too few to draw firm conclusions about the methods.
A screening programme has to be practical, reliable, valid, and reasonably low in cost. 11 12 The CAPAS test is more practical than the Ewing test. However, the Ewing test seemed to be more reliable and valid for detecting persistent OME, and hence a better tool in daily practice.
As we have not performed a randomised study we cannot claim to have produced unbiased estimates of diVerences in screen variables. However, it is not likely that diVerences in epidemiology or diagnosis between the two health districts cancelled out a genuine diVerence between the tests. We therefore conclude that so long as these screens remain in place and have as one of their aims the early detection of conductive loss, both types of test are acceptable options. To prompt a firm policy recommendation in favour of one or other test, stronger evidence-for example of harm to undetected and untreated cases, is required. A decision can therefore be made based on cost eVectiveness.
